InvestorsHub Logo
Followers 24
Posts 1721
Boards Moderated 0
Alias Born 08/07/2022

Re: 12x post# 423318

Tuesday, 07/18/2023 10:09:51 AM

Tuesday, July 18, 2023 10:09:51 AM

Post# of 462332
45% reduction for 2-73 paitients at 48 weeks, 12x, as you know,

The huge placebo response in the dononemab trial is remarkable all by itself: 3 in 10 placebo AD patients had zero progression (or maybe even improved.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News